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A unique polypeptide, called enhancing factor (EF), which enhances the binding of labeled epidermal 
growth factor (EGF) to cells, has been isolated. It has been purified to homogeneity from the acid-soluble 
proteins of mouse intestines. Earlier, EF was partially purified by two cycles of gel-permeation chroma- 
tography on Bio-Gel columns. We now report the final purification of EF on high-performance liquid chro- 
matography (HPLC), using a reverse-phase column bBondapak C18). The purity of the protein was con- 
firmed when a single peak was obtained in HPLC. Also, a single protein band was obtained in SDS-PAGE. 
Purified EF has the same properties in vitro as those reported earlier for partially purified EF. 
Growth factor HPLC 
1. INTRODUCTION 
A polypeptide, which enhances the binding of 
labeled epidermal growth factor (EGF) to the cell 
membrane in a radioreceptor assay, has been 
isolated from normal mouse intestines. This 
polypeptide is termed ‘enhancing factor’ (EF) [ 11. 
EF binds to the cell membrane via its own receptor 
and in turn provides a binding site for EGF [2]. In 
vitro, EF makes EGF available to quiescent cells, 
even in the absence of functional EGF receptors, 
thereby stimulating DNA synthesis [2]. In the 
earlier studies, EF was partially purified, after 
acid/ethanol extraction of mouse intestines, and 
gel filtration of the acid-soluble proteins on Bio- 
Gel columns [l]. Here, the total purification to 
homogeneity of the EF using HPLC is described. 
2. MATERIALS AND METHODS 
EF was extracted from normal mouse small in- 
testines following the acid/ethanol extraction pro- 
cedure of Roberts et al. [3]. It was partially 
purified on Bio-Gel P-100 and P-60 columns and 
tested in the ‘251-EGF-receptor binding assay on 
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fixed A431 cells as described in [1,2]. Fractions 
eluted from the Bio-Gel P-60 column showing 
enhancing activity greater than 50% were pooled 
(EF-P-60) and subjected to purification by HPLC 
(Waters Associates). 2-3 mg EF-P-60 was 
lyophilised, reconstituted in 100 ~1 of 0.1% 
trifluoroacetic acid (TFA) (Fluka) in water and in- 
jected into a semipreparative reverse-phase (RP) 
column @Bondapak C18; Waters, 7.8 x 300 mm) 
equilibrated with 0.1% TFA. A gradient of 
acetonitrile (Spectrochem, India, HPLC grade) 
with 0.1% TFA was applied at a flow rate of 
1 ml/min for 40 min (fig.1). Elution was 
monitored at 280 nm. Each peak was collected 
separately and tested in the ?-EGF-binding 
radioreceptor assay as in [ 11. The peak showing ac- 
tivity (EF-HPLC-I) was rerun on the same column, 
under identical conditions. The peak with activity 
was again collected (EF-HPLC-II) and subjected 
to electrophoresis and amino acid analysis. 
Protein concentration was determined as 
described by Hartree [4], using bovine serum 
albumin (BSA) as standard. SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) was carried out in 
a 17.5% slab gel in the buffer system of Laemmli 
[5]. Standard markers including BSA (MT 68000), 
carbonic anhydrase (Mr 29000), RNase (MI 13 800) 
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and insulin (Mr 6000) were used. Proteins were 
stained with 0.25% Coomassie brilliant blue R250. 
2.5-5 nM EF was hydrolysed in 500 ~1 of 6 N HCI 
under vacuum at 1lO’C for 22 h. Amino acid 
analysis was performed on an LKB amino acid 
analyser. 
3. RESULTS AND DISCUSSION 
The partially purified EF from two cycles on the 
Bio-Gel column was further purified on HPLC on 
an RP column. Fig.1 shows the protein profile 
recorded at 280 nm and the gradient of acetonitrile 
with 0.1% TFA. Each peak was collected separate- 
ly and tested in the A431 radioreceptor assay as 
described [l]. Only one peak, which eluted with a 
retention time of 30.08 min (47% acetonitrile), 
showed enhancing activity. This peak (EF-HPLC- 
I) was collected and recycled through the same RP 
column, under identical conditions. The EF peak 
eluted as a single peak with a similar retention time 
of 29.86 min (46.6% acetonitrile) (fig.2) and show- 
ed a 90% increase in the binding of “‘1-EGF in the 
radioreceptor assay. 
EF, eluted at different steps in the purification 
procedure, has been analysed on SDS-PAGE 
(fig.3). EF eluted from Bio-Gel P-100 (EP-PlOO) 
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Fig.1. HPLC profile of EF-P-60 on a pBondapak Cl8 
column. 2-3 mg lyophilised protein was reconstituted in 
100 pl of 0.1% TFA and injected. Elution was 
performed with a 40 min, O-80% acetonitrile gradient in 
0.1% TFA (---), at a flow rate of 1 ml/min. 
Absorbance was measured at 280 nm (-). Peak 
fractions were collected, lyophilised and tested in the 
“‘I-EGF-binding assay as described in [l]. 
Fig.2. Rechromatography of EF-HPLC-I on a 
PBondapak Cl8 column under conditions identical to 
those described in fig. 1. The 30.08 min peak obtained 
from the 1st cycle HPLC was collected, lyophilised, 
reconstituted in 0.1% TFA and injected. 
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Fig.3. SDS-PAGE of EF at different steps of 
purification. 50 pg protein was dissolved in 60 ~1 sample 
buffer with 2-mercaptoethanol and heated for 3 min at 
100°C. The samples were then applied to a 1.5 mm, 
17.5% acrylamide gel with a 3% acrylamide stacking 
gel. The gel was fixed in methanol: acetic acid: water 
(5: 1:5) and stained with Coomassie brilliant blue. 
Lanes: 1, acid-soluble proteins from mouse intestines; 2, 
EF-P-100; 3, EF-P-60; 4, EF-HPLC-I; 5, EF-HPLC-II. 
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and Bio-Gel P-60 (EF-P-60) shows 3-4 bands 
whereas EF-HPLC-II purified after 2 cycles of 
HPLC shows a single major protein band. EF has 
an I%& of 14000 as calculated on 17.5% SDS- 
PAGE, using standard A4, markers. However, 
when calculated from the Bio-Gel P-100 elution 
profile, EF elutes immediately after cytochrome c 
(Mr 12500) and has an apparent M, of 12000. The 
purified EF gives a single peak when injected on 
the RP column in HPLC. As seen from table 1, EF 
has been purified 2000-fold from the crude in- 
testinal acid-soluble proteins. Approx. 500 ng 
purified EF is obtained from 1 mg acid-soluble 
proteins. There is a substantial loss in activity 
which could be due to specific loss of the EF pro- 
tein or its denaturation or to separation of its ac- 
tivator during purification. The exact reason, 
which is not known, is being investigated. 
The amino acid composition of the purified 
polypeptide is shown in table 2. The number of 
residues per molecule is assigned tentatively, 
assuming an apparent Mr of 14000. The amino 
acid composition is distinct from other growth fac- 
tors like TGF-/3 [6,7] isolated under identical con- 
ditions. Purified EF, like EF-P-60 at high 
concentrations [2], stimulates DNA synthesis in 
quiescent cells and acts synergistically with EGF 
when sub-mitogenic concentrations of both EF 
and EGF are added (not shown). Preliminary 
studies show that 18 h after hepatectomy, the acid- 
soluble extract of liver passed through RP-HPLC, 
has a small peak of enhancing activity. This activi- 
ty elutes at a similar concentration of acetonitrile 
Table 1 
Stepwise purification of EF from intestines of mice 
Purification Total Total Specific 
step protein unitsa activity 
(mg) (U/mg) 
Acid-soluble extract 69.6 - - 
EF-P-100 14.8 1850 125 
EF-P-60 6.0 1200 200 
EF-HPLC-I 0.079 26 329 
EF-HPLC-II 0.035 70 2000 
a 1 U activity is defined as the amount of protein (mg) 
required for 50% enhancing activity in “‘1-EGF- 
receptor binding assay, using fixed A431 cells, as 
described in [l] 
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Table 2 
Amino acid analysis of EF 
Amino acid No.of re- Amino acid No.of re- 
sidues/mol sidues/mol 
(mean * (mean f 
SD) SD) 
Aspartic acid 9 * 0.5 methionine 3*0 
Threonine 5 + 0.5 isoleucine 3&O 
Serine 9 + 0.5 leucine 7 + 0.8 
Glutamic acid 14 + 0.8 tyrosine 4+ 1.0 
Proline 4 + 0.8 phenylalanine 5 f 0.4 
Glycine 14 + 1.9 histidine 350 
Alanine 9& 1.6 lysine 15 + 1.0 
Cysteine 3&O arginine 6 + 0.5 
Valine 3 t 0.8 
EF was hydrolysed in 6 N HCI at 110°C for 24 h in 
sealed, evacuated ampoules. Values are based on 4 
separate determinations of 4 different preparations. The 
number of residues per mole is based on an apparent A4, 
of 14000 
to intestinal EF. EF appears to play a role in cell 
proliferation by modulating the action of growth 
factors. To our knowledge, this is the first report 
of purification of a local modulator of growth fac- 
tors from the intestine of normal mouse. 
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